ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
38 | (±¹³»)SCI | Predictors of Pulmonary Function Response to Treatment with Salmeterol/fluticasone in Patients with Chronic Obstructive Pulmonary Disease |
37 | (±¹¿Ü)SCI | Pulmonary artery pressure in chronic obstructive pulmonary disease without resting hypoxaemia |
36 | (±¹³»)SCOPUS | A Rare Case of Fat-Forming Variant of Solitary Fibrous Tumor Presenting as a Pleural Mass |
35 | (±¹³»)SCOPUS | ±¹³» ¹Î°£º´¿ø¿¡¼ Ä¡·áÇÑ ´ÙÁ¦³»¼º°áÇ٠ȯÀÚÀÇ Ä¡·á °á°ú ¹× ¿¹ÈÄ ÀÎÀÚ |
34 | (±¹¿Ü)SCI | Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema |
33 | (±¹³»)±âŸ | small cell lung cancer at subcarina presenting as a metastatic brain tumor |
32 | (±¹¿Ü)SCI | Three phenotypes of obstructive lung disease in the elderly |
31 | (±¹¿Ü)SCIE | Association of endothelial nitric oxide synthase polymorphisms and haplotypes with ischemic stroke in Korean individuals with or without diabetes mellitus |
30 | (±¹¿Ü)SCI | Treatment Outcomes and Survival Based on Drug Resistance Patterns in Multidrug-resistant Tuberculosis |
29 | (±¹¿Ü)SCI | p16Ink4a Suppression of Lung Adenocarcinoma by Bmi-1 in the Presence of p38 Activation |
Copyright ¨Ï chamc, All rights reserved.